
Biocon Pharma gets DCGI nod for diabetes drug liraglutide in India
New Delhi, June 3 (UNI) Biocon Pharma Limited, a biopharmaceutical firm, on Tuesday said that drug regulator, Drugs Controller General of India under the CDSCO (Central Drugs Standard Control Organisation) has given nod to its liraglutide drug for Indian market. The approval is for the generic version of Victoza, indicated for the treatment of insufficiently…